BackRecro Pharma Overview

Recro Pharma Total Revenue

Revenue analysis for REPH.

Quarterly Revenue

$27.72M
↑ 14.17% YoY

As of Dec 2023

Annual Revenue (TTM)

$94.64M
↑ 4.9% YoY

Trailing 12 months ending Dec 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin